Cargando…
Absence of myofibrillar myopathy in Quarter Horses with a histopathological diagnosis of type 2 polysaccharide storage myopathy and lack of association with commercial genetic tests
BACKGROUND: Genetic tests for variants in MYOT (P2; rs1138656462), FLNC (P3a; rs1139799323 or P3b; rs1142918816) and MYOZ3 (P4; rs1142544043) genes are offered commercially to diagnose myofibrillar myopathy (MFM) and type 2 polysaccharide storage myopathy (PSSM2) in Quarter Horses (QH). OBJECTIVES:...
Autores principales: | Valberg, Stephanie J., Henry, Marisa L., Herrick, Keely L., Velez‐Irizarry, Deborah, Finno, Carrie J., Petersen, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084132/ https://www.ncbi.nlm.nih.gov/pubmed/35288976 http://dx.doi.org/10.1111/evj.13574 |
Ejemplares similares
-
Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis
por: Valberg, Stephanie J., et al.
Publicado: (2020) -
Integrated proteomic and transcriptomic profiling identifies aberrant gene and protein expression in the sarcomere, mitochondrial complex I, and the extracellular matrix in Warmblood horses with myofibrillar myopathy
por: Williams, Zoë J., et al.
Publicado: (2021) -
Proteome and transcriptome profiling of equine myofibrillar myopathy identifies diminished peroxiredoxin 6 and altered cysteine metabolic pathways
por: Valberg, Stephanie J., et al.
Publicado: (2018) -
Prevalence of clinical signs and factors impacting expression of myosin heavy chain myopathy in Quarter Horse‐related breeds with the
MYH1
(E321G)
mutation
por: Valberg, Stephanie J., et al.
Publicado: (2022) -
Myofibre Hyper-Contractility in Horses Expressing the Myosin Heavy Chain Myopathy Mutation, MYH1(E321G)
por: Ochala, Julien, et al.
Publicado: (2021)